Castle Private Equity AG

Private Equity Holding AG implements a comprehensive investment strategy, primarily through fund-of-funds, secondary indirect investments, and carefully selected direct co-investments. Its fund-of-funds approach spans various categories, including venture, buyout, special situation, secondary, and balanced funds, with a specific exclusion of very early-stage venture capital and mega-buyout funds. Within its venture fund allocations, a strong emphasis is placed on technology sectors such as Internet, telecommunications, information technology, life sciences, and other high-tech areas like semiconductors and electronics. For direct participation, the company typically opts to co-invest alongside partner funds or offer pre-IPO financing in the form of convertible loans. Its investment scope is wide-ranging, encompassing businesses at diverse stages and scenarios, from mid-to-late venture, middle-market, and developmental phases, to management buyouts and buy-ins, succession issues, bridge financings, spin-offs, distressed and turnaround situations, and mature companies. It also considers Private Investment in Public Equity (PIPES). Geographically, Private Equity Holding AG focuses on developed European markets, with particular attention to Switzerland, Germany, France, and the United Kingdom, alongside Central and Eastern Europe, Israel, and the United States. For expansion or development capital, it targets companies generating annual revenues exceeding $1 million. The firm channels most of its investments through offshore entities and generally aims to secure a controlling interest.

HBM Healthcare Investments AG strategically deploys capital through both direct investments and allocations to other funds, targeting middle-market and mature companies. Its investment mandate is broad, encompassing various stages from nascent startups, early-stage, mid-stage, and late-stage private ventures to emerging unlisted businesses, smaller public companies, management buyouts, growth capital opportunities, and private investments in public equities (PIPEs). Within its fund-of-funds segment, it specifically backs venture capital funds. The firm also provides financing for the spin-off of product lines or departments from larger corporations, supports the expansion or restructuring of established businesses, and participates in seed, venture, and expansion capital rounds, along with additional buyout transactions. HBM's primary focus is on private and public entities within the healthcare sector, with a strong emphasis on human medicine, pharmaceuticals (including biopharma), biotechnology, diagnostics, medical technology, and related industries. Initial investments are typically made in companies whose core products are either in clinical development or the stage immediately preceding it. The fund adopts a global investment approach, concentrating its efforts particularly on the Asia Pacific region, North America, and Europe. For publicly listed companies, HBM generally targets those that have transitioned from its private investment portfolio. The firm often increases its stake in portfolio companies by participating in subsequent financing rounds or after the company's initial public offering. HBM may acquire controlling interests in portfolio companies and frequently secures a seat on their Board of Directors. While equity investments are its predominant method, it also utilizes a range of other financial instruments, including convertible bonds, debt securities, structured products, and derivatives. HBM's primary exit strategies for its portfolio companies involve trade sales or initial public offerings.

JPEL Private Equity Limited operates as an investment vehicle concentrating on three distinct strategies: direct equity stakes, secondary direct acquisitions, and allocations to other funds. Its primary capital deployment targets include buyout, venture capital, and special situations funds. The firm maintains a global investment mandate, although it particularly emphasizes opportunities across Europe, North America, and Asia. For its direct investment activities, JPEL frequently seeks to co-invest in collaboration with other private equity sponsors.

EPE Special Opportunities plc operates as an investment firm employing a diverse array of strategies, including involvement in mid-market transactions, providing growth capital, investing in distressed assets, supporting pre-initial public offering companies, addressing special situations, facilitating business turnarounds, engaging in private investments in public equity (PIPEs), and conducting leveraged buyouts. Furthermore, the company participates in both direct and indirect secondary market investments. Its investment focus spans sectors such as consumer and retail, financial services, manufacturing, media, and support services, with a particular interest in education, healthcare, and social housing. Geographically, the firm predominantly seeks opportunities within the United Kingdom. It aims to allocate between $2 million and $30 million into small and medium-sized enterprises (SMEs), investing in both privately held and publicly traded entities. EPE Special Opportunities typically targets an exit horizon of one to five years for its positions and generally acquires minority stakes.

ICG ENTERPRISE TRUST PLCICGT · Asset ManagementLondon, United Kingdom

70% matchPublic

ICG Enterprise Trust PLC primarily deploys capital through two distinct avenues: direct investments and commitments to various private equity funds. The Trust expressly avoids early-stage or venture capital funding, instead focusing on providing growth capital. Its direct investment strategy often involves co-investing in established companies undergoing buyouts. Within its fund-of-funds allocations, the Trust targets primary and secondary purchases of private equity buyout funds, growth capital funds, and mezzanine funds. The Trust maintains a broad sector focus, encompassing healthcare, education, industrial companies, business and consumer services, leisure, technology, media, telecommunications, and financial institutions, among others. Geographically, direct investments in unquoted companies and primary fund commitments span all industry sectors across Europe, with a particular emphasis on the United Kingdom and Western Europe. For its broader fund-of-funds strategy, the geographic scope also extends to the United States. The Trust typically seeks to deploy between $100 million and $200 million, targeting companies with an enterprise value ranging from £25 million ($40.62 million) to £200 million ($324.94 million). Investments within the UK middle market are frequently channeled through funds managed by Graphite Capital Management LLP, while broader European and UK middle-market exposure is gained via third-party fund commitments. Additionally, the Trust participates in co-investments alongside its portfolio funds, acquires stakes in existing funds through secondary market transactions, and explores opportunities in emerging sectors, such as public finance initiatives, and with new fund managers.

HG CAPITAL TRUST PLCHGT · Asset ManagementLondon, United Kingdom

68% matchPublic

HgCapital Trust plc (2017) strategically allocates capital to a diverse range of opportunities, encompassing direct investments in both publicly traded and privately held companies, as well as participations in fund-of-funds arrangements. The trust permits its entire gross asset base (100%) to be exposed to unlisted investments. However, it imposes a strict limit, ensuring that no individual direct or indirect investment in an unlisted company or closed-ended fund exceeds 15% of its gross assets. The primary focus for its direct investments lies in middle-market buyouts across the Technology, TMT, Services, and Industrials Technology sectors, targeting businesses with enterprise values between £80 million (approximately $97.43 million) and £500 million (approximately $608.95 million). It also seeks lower mid-market buyout prospects specifically within the TMT sector, focusing on companies valued from £20 million (approximately $24.35 million) to £80 million (approximately $97.43 million). Beyond these, the fund explores direct investments in hospitality (hotels, restaurants, leisure), consumer durables and apparel, various service industries, and renewable energy. Geographically, HgCapital Trust prioritizes investments within Europe, with a distinct emphasis on Northern Europe, including the United Kingdom, Germany, France, the Benelux region, and the Nordics, alongside other European territories. The trust typically commits between £100 million (approximately $202.89 million) and £500 million (approximately $1014.45 million) to each of its portfolio companies. For its fund-of-funds segment, it specifically invests in limited partnership vehicles overseen by HgCapital. A cornerstone of its investment philosophy is to secure a majority ownership stake in the businesses it supports.